"By taking advantage of the global distribution network that AMT already has in place, CrownBeav expects to see a quick and dramatic expansion of our global sales," says Pete Pifer, President and CEO of CrownBeav LLC, adding, "AMT will be able to bring the DirectCrown family of products to countries and markets that were previously unavailable to us."
"DirectCrown has universal appeal," says Judd D. Hoffman, President and CEO of AMT. "AMT is very excited to represent such an innovative and cost-effective family of products that we believe will meet customers' needs around the world."
About AMT:
American Medical Technologies, Inc., headquartered in Corpus Christi, Texas, markets and sells unique dental products to the international dental community through its established global federation of dealers and distributors. Its premier product, Contrast professional tooth whitening, delivers excellent whitening results at low costs. AMT is currently in negotiations with several manufacturers and expects to introduce new products to its international brokering network in the coming few months. AMT was incorporated in Delaware in November 1989 and completed its initial public offering in June 1991. AMT changed its name from American Dental Technologies, Inc. on July 13, 2000. www.americanmedicaltech.com
The Company makes forward-looking statements in this press release and in its filings with the Securities and Exchange Commission. The Company's forward-looking statements are subject to risks and uncertainties and include information about its expectations and possible or assumed future results of operations. When the Company uses any of the words "believes," "expects," "anticipates," "estimates," or similar expressions, it is making forward-looking statements. AMT's actual results, performance or achievements could differ materially from the results expressed in, or implied by these forward-looking statements. For more detailed information relating to the risks and uncertainties pertaining to these forward-looking statements, the reader is referred to the "risk-factor" section in AMT's form 10-KSB and other related documents filed with the Securities and Exchange Commission.
SOURCE: American Medical Technologies, Inc.
American Medical Technologies, Inc., Corpus Christi Judd D. Hoffman, 361-289-1145 President and CEO Copyright Business Wire 2007
